110658-33-8

Upstream product

• 85-44-9 phthalic anhydride 
• 16338-48-0 L-allylglycine 

Downstream Products

• 762289-38-3 N-(cyclopropylmethyl)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-(1-phenylprop-2-en-1-yl)-pent-4-enamide 
• 84688-14-2 benzyl (S)-2-(1,3-dioxoisoindolin-2-yl)-6-oxohexanoate 
• 1228152-53-1 benzyl (S)-2-(1,3-dioxoisoindolin-2-yl)pent-4-enoate 
• 762289-45-2 N-benzyl-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(1S)-1-phenylprop-2-en-1-yl]-pent-4-enamide 
• 762289-71-4 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-isobutyl-N-[(1S)-1-phenylprop-2-en-1-yl]pent-4-enamide 
• 762289-53-2 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-(2-methoxyethyl)-N-[(1S)-1-phenylprop-2-en-1-yl]pent-4-enamide 
• 635291-67-7 methyl 2-[2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)pent-4-enoyl]-1-benzyloxycarbonylpyrazolidine-3-carboxylate 
• 916049-29-1 5-(dimethylphenylsilyl)-1-[2-(1,3-dioxo-1,3-dihydroisoindol-2-yl)pent-4-enoyl]pyrrolidine-2-carboxylic acid methyl ester 

Relevant academic research and scientific papers

SUBSTITUTED PYRAZOLE AND TRIAZOLE COMPOUNDS AS KSP INHIBITORS

Disclosed are new substituted pyrazole and triazole compounds of Formula (I) and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses thereof

Substituted imidazole compounds as KSP inhibitors

The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses of the compounds. The compounds of the invention have the following general formula: